文献速递腹部CT

CT诊断肝脂肪变的诊断准确性:系统综述与荟萃分析

Diagnostic Accuracy of CT for the Detection of Hepatic Steatosis: A Systematic Review and Meta-Analysis.
PubMed 文献 · Radiology · 2024-01-01

该系统综述与荟萃分析纳入42项研究(14186例受试者),评估非增强CT、增强CT和双能CT对肝脂肪变的诊断准确性,并与活检、MRI质子密度脂肪分数或非增强CT参考标准比较。非增强CT检测至少中度脂肪变(活检脂肪>20%-33%)的敏感度和特异度分别为82%和94%;肝衰减<40-45 HU、肝脾衰减差<-5至0 HU、肝脾衰减比<0.9-1对至少中度脂肪变具有高特异度。

要点

  • 非增强CT检测至少中度肝脂肪变(活检脂肪>20%-33%)敏感度82%、特异度94%。
  • 肝衰减<40-45 HU、肝脾衰减差<-5至0 HU、肝脾衰减比<0.9-1对至少中度脂肪变特异度高。
  • 增强CT和双能CT研究间存在异质性,需结合参考标准解读其诊断性能。

核心结论

  • 非增强CT对检测至少中度肝脂肪变表现出高性能。

研究设计与样本

  • 系统综述与荟萃分析,纳入42项研究(14186例受试者),检索PubMed、Embase和Scopus数据库(1977年9月至2024年1月发表的英文研究),评估非增强CT、增强CT和双能CT检测肝脂肪变的诊断准确性,参考标准包括活检、MRI质子密度脂肪分数或非增强CT。

诊断标准与关键数值

  • 非增强CT检测脂肪变(活检脂肪>5%)的敏感度72%、特异度88%。
  • 非增强CT检测至少中度脂肪变(活检脂肪>20%-33%)的敏感度82%、特异度94%。
  • 增强CT检测脂肪变的敏感度66%、特异度90%;检测至少中度脂肪变的敏感度68%、特异度93%。
  • 双能CT检测脂肪变的敏感度85%、特异度88%。
  • 亚组分析中,增强CT检测脂肪变的敏感度80%、特异度99%;双能CT的敏感度84%、特异度93%。

局限性

  • 关注增强CT和双能CT的研究间存在异质性。
  • 在多项增强CT和双能CT研究中,非增强CT被用作参考标准,因此需要进行亚组分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background CT plays an important role in the opportunistic identification of hepatic steatosis. CT performance for steatosis detection has been inconsistent across various studies, and no clear guidelines on optimum thresholds have been established. Purpose To conduct a systematic review and meta-analysis to assess CT diagnostic accuracy in hepatic steatosis detection and to determine reliable cutoffs for the commonly mentioned measures in the literature. Materials and Methods A systematic search of the PubMed, Embase, and Scopus databases (English-language studies published from September 1977 to January 2024) was performed. Studies evaluating the diagnostic accuracy of noncontrast CT (NCCT), contrast-enhanced (CECT), and dual-energy CT (DECT) for hepatic steatosis detection were included. Reference standards included biopsy, MRI proton density fat fraction (PDFF), or NCCT. In several CECT and DECT studies, NCCT was used as the reference standard, necessitating subgroup analysis. Statistical analysis included a random-effects meta-analysis, assessment of heterogeneity with use of the I2 statistic, and meta-regression to explore potential sources of heterogeneity. When available, mean liver attenuation, liver-spleen attenuation difference, liver to spleen attenuation ratio, and the DECT-derived fat fraction for hepatic steatosis diagnosis were assessed. Results Forty-two studies (14 186 participants) were included. NCCT had a sensitivity and specificity of 72% and 88%, respectively, for steatosis (>5% fat at biopsy) detection and 82% and 94% for at least moderate steatosis (over 20%-33% fat at biopsy) detection. CECT had a sensitivity and specificity of 66% and 90% for steatosis detection and 68% and 93% for at least moderate steatosis detection. DECT had a sensitivity and specificity of 85% and 88% for steatosis detection. In the subgroup analysis, the sensitivity and specificity for detecting steatosis were 80% and 99% for CECT and 84% and 93% for DECT. There was heterogeneity among studies focusing on CECT and DECT. Liver attenuation less than 40-45 HU, liver-spleen attenuation difference less than -5 to 0 HU, and liver to spleen attenuation ratio less than 0.9-1 achieved high specificity for detection of at least moderate steatosis. Conclusion NCCT showed high performance for detection of at least moderate steatosis. © RSNA, 2024 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Haghshomar M, Antonacci D, Smith AD, et al. Diagnostic Accuracy of CT for the Detection of Hepatic Steatosis: A Systematic Review and Meta-Analysis. Radiology. 2024. PMID: 39499183. doi:10.1148/radiol.241171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。